innovation dafabet live dealer game
deserve medications that offer flexibility and longer lasting benefit
Many available attention-deficit/hyperactivity disorder (dafabet online betting website) therapies are associated with significant drawbacks that create additional burden for patients. Our portfolio of leading dafabet online betting website medicines harnesses the innovative capabilities of our proprietary LiquiXR® technology to reduce these drawbacks and improve treatment outcomes for adults and children with dafabet online betting website.
Understanding dafabet online betting website is critical to improving outcomes
Living with dafabet online betting website can be a debilitating struggle that can cause mood swings and impulsiveness, and make it difficult to pay attention. Untreated dafabet online betting website symptoms can have a significant negative impact across an individual’s daily life, including school and work performance, as well as the quality of social interactions and relationships.1 Medication can help patients function better throughout the day; however, many approved treatments don’t meet all the needs of dafabet online betting website patients for flexibility, consistency and duration of effect.
Our flexible technology, which is designed around the needs of patients, differentiates our portfolio of five leading dafabet online betting website therapies that encompass a range of multiple delivery options uniquely tailored to patients’ needs.
How Well Do You Know dafabet online betting website?
-
- dafabet online betting website is pervasive in children and adults. In the United States, approximately six million children (nearly one in 10) and eight million adults have dafabet online betting website. 2,3
- Children commonly receive treatment. According to the Centers for Disease Control and Prevention (CDC), approximately three in four children with dafabet online betting website receive treatment, including medication and/or behavioral therapy.2
- Many adults are left behind. Studies suggest that over 80% of adult dafabet online betting website cases are currently untreated and/or undiagnosed by a psychiatrist.3
- Females are diagnosed later in life. Studies point to gender differences in dafabet online betting website, with females showing more inattention (versus hyperactive and impulsive) symptoms and typically receiving an dafabet online betting website diagnosis later than males.4
-
- dafabet online betting website negatively impacts driving capabilities. Drivers with dafabet online betting website are more likely to have a license revoked or suspended and have a higher incidence of crashes and traffic citations. 5
- dafabet online betting website is not a consistent condition. The severity of symptoms can vary from patient to patient, as well as fluctuate on a daily basis.
- Undiagnosed and untreated dafabet online betting website is associated with poor outcomes. These may include adverse driving events, poor performance at school and work, and comorbid conditions, including substance use disorder, personality disorder, mood instability and obesity.1,6
- The precise cause of dafabet online betting website is not fully known. Differences in brain structure and chemistry are at the core of dafabet online betting website, but environmental and genetic factors may also play a role.7
Our LiquiXR® technology allows for medicines that:8-9
have extended-release of medication- dafabet online betting website tailored with a smooth, consistent release profile
- are available as liquid or tablet
- have flexible dosing options
The LiquiXR® difference: continuous delivery to address patient variability
Our proprietary LiquiXR® technology allows us to create dafabet online betting website medications in a variety of formulations that are flexible and allow precise, consistent drug release to patients despite their individual needs and differences. This patented technology is built around a unique diffusion coating. When the coating is applied in many different thicknesses to carrier particles with the drug attached, the therapy can be tailored to provide a consistent and continuous release of medication over a targeted duration.
For more information on our dafabet online betting website medicines, visit www.TrisADHD.com
1 Shaw, M., Hodgkins, P., Caci, H., et al. (2012). A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment. BMC Medicine, 10, 99.
2 Bitsko R., Claussen A., Lichstein J., et al. (2022). Mental Health Surveillance Among Children — United States, 2013–2019. MMWR. Suppl 2022;71(Suppl-2):1–42.
3 Ginsberg, Y., Quintero, J., Anand, E., et al. (2014). Underdiagnosis of attention-deficit/hyperactivity disorder in adult patients: a review of the literature. The primary care companion for CNS disorders, 16(3), PCC.13r01600.
4 Gershon, J., & Gershon, J. (2002). A Meta-Analytic Review of Gender Differences in dafabet online betting website. Journal of Attention Disorders, 5(3), 143-154. https://doi.org/10.1177/108705470200500302
5 Barkley, R. A., Murphy, K. R., Dupaul, G. I., & Bush, T. (2002). Driving in young adults with attention deficit hyperactivity disorder: knowledge, performance, adverse outcomes, and the role of executive functioning. Journal of the International Neuropsychological Society (JINS), 8(5), 655–672.
6 Matza, L. S., Paramore, C., & Prasad, M. (2005). A review of the economic burden of dafabet online betting website. Cost Effectiveness and Resource Allocation: C/E, 3,5.
7 Faraone, S.V., Larsson, H. Genetics of attention deficit hyperactivity disorder. Mol Psychiatry 24, 562–575 (2019). https://doi.org/10.1038/s41380-018-0070-0
8 Pardo A, Kando JC, King TR, Rafla E, Herman BK. Single-dose pharmacokinetics of amphetamine extended-release tablets compared with amphetamine extended-release oral suspension. CNS Spectr. 2020;25(6):774-781.
9 Kando JC, King TR, Pardo A. A novel, modified release drug delivery technology containing amphetamine and methylphenidate ion-exchange complexes. Poster presented at American Psychiatric Association Annual Meeting; May 1-3, 2021.